Nelfinavir is an orally administered drug that belongs to a treatment classification called protease inhibitors. Preclinical data suggests that Nelfinavir may overcome resistance to proteasome inhibitors in multiple myeloma.
| SparkCures ID | 323 |
|---|---|
| Brand Name | Viracept® |
| Generic Name | Nelfinavir |
| Treatment Classifications |
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.